SYNTHESIS OF ANTAGONISTS OF MUSCARINIC (M3) RECEPTORS

被引：2

作者：

Broadley, Kenneth J. ^{[3
]}

Davies, Robin H. ^{[2
]}

Escargueil, Christine ^{[3
]}

Lee, Alan T. L. ^{[1
]}

Penson, Peter ^{[3
]}

Thomas, Eric J. ^{[1
]}

机构：

[1] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England

[2] Muscagen Ltd, Cardiff CF10 3DFY, S Glam, Wales

[3] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3NB, S Glam, Wales

来源：

COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS | 2011年 / 76卷 / 07期

关键词：

Muscarinic receptors; Antagonists; Suzuki-Miyaura coupling; alpha-Hydroxyamides; Alcohols; Amides; Biological activity; Medicinal chemistry; HIGH SELECTIVITY; OXIDATION; ALDEHYDES; ALCOHOLS;

D O I：

10.1135/cccc2011017

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Several alpha-hydroxyamides with (2,6-dialkoxyphenoxy) methyl substituents have been prepared and their activities as antagonists of the M-3 muscarinic receptor in guinea pig ileum have been evaluated. N-{1-[(Phenyl)methyl]piperidin-4-yl}-2-{2-[(2,6-dimethoxyphenoxy)methyl]phenyl}-2-hydroxypropanamide and N-(1-[{6-amino-4-[(1-propylpiperidin-4-yl)methyl]pyridin-2-yl}methyl]piperidin-4-yl)-2-cyclopentyl-2-hydroxy-2-phenylacetamide were the most potent compounds prepared, the micromolar potency of the latter indicating that it may be worth further investigation.

引用

页码：781 / 801

页数：21

共 50 条

[21] Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor
Dowling, Mark R.
Charlton, Steven J.
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) : 927 - 937
[22] Evidence for precoupling of inactive M3 muscarinic receptors and Gq Protein
Qin, Kou
Sudha, Kuravi K.
Lambert, Nevin A.
BIOPHYSICAL JOURNAL, 2009, 96 (03) : 674A - 674A
[23] M3 muscarinic receptors as targets for drug development in neurodegenerative disorders
Dragunow, Mike
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (02) : 185 - 185
[24] A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma
Matera, Maria Gabriella
Rinaldi, Barbara
Berardo, Carmela
Rinaldi, Michele
Cazzola, Mario
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (02) : 143 - 148
[25] Critical metabolic roles of β-cell M3 muscarinic acetylcholine receptors
de Azua, Inigo Ruiz
Gautam, Dinesh
Jain, Shalini
Guettier, Jean-Marc
Wess, Juergen
LIFE SCIENCES, 2012, 91 (21-22) : 986 - 991
[26] M3 muscarinic receptors mediate contraction of human urinary bladder
Fetscher, C
Fleichman, M
Schmidt, M
Krege, S
Michel, MC
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (05) : 641 - 643
[27] M3 muscarinic receptors as targets for drug development in neurodegenerative disorders
Mike Dragunow
Nature Reviews Drug Discovery, 2008, 7 : 185 - 185
[28] Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity
Sagara, Yufu
Sagara, Takeshi
Uchiyama, Minaho
Otsuki, Sachie
Kimura, Toshifumi
Fujikawa, Toru
Noguchi, Kazuhito
Ohtake, Norikazu
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (19) : 5653 - 5663
[29] Muscarinic M1 and M3 receptors in rat striatum:: A binding study
De la Vega, MT
Nunez, A
Arias-Montano, JA
ARCHIVES OF MEDICAL RESEARCH, 1997, 28 (04): : 493 - 497
[30] Contribution of M2 and M3 Muscarinic Receptors in Small Airway Contraction
Brown, S. M.
Sturton, R. G.
Koarai, A.
Barnes, P. J.
Donnelly, L. E.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179

← 1 2 3 4 5 →